Home

warm Steigung Senf teva class action Arashigaoka Küste Atlas

Teva fueled opioid addiction in New York, jury finds | Crime | POST Online  Media
Teva fueled opioid addiction in New York, jury finds | Crime | POST Online Media

Purdue Pharma, others could deduct opioid settlements from taxes
Purdue Pharma, others could deduct opioid settlements from taxes

Teva settles shareholder lawsuit over generic drug pricing for $420 mln |  Reuters
Teva settles shareholder lawsuit over generic drug pricing for $420 mln | Reuters

Teva Pharmaceuticals is found liable in the opioid crisis : NPR
Teva Pharmaceuticals is found liable in the opioid crisis : NPR

$24M Class Action Settlement Reached with Teva Over Nexium Pay-for-Delay -  Top Class Actions
$24M Class Action Settlement Reached with Teva Over Nexium Pay-for-Delay - Top Class Actions

Class Action Update - Claim Your Cash (December, 2019)
Class Action Update - Claim Your Cash (December, 2019)

Teva Stock: Legal Risks Offer Setup For A Strangle Or Straddle (NYSE:TEVA)  | Seeking Alpha
Teva Stock: Legal Risks Offer Setup For A Strangle Or Straddle (NYSE:TEVA) | Seeking Alpha

Buy Teva Pharmaceuticals amid positive news, Bernstein says
Buy Teva Pharmaceuticals amid positive news, Bernstein says

Teva is primed for a big bounce after years of underperformance, Barclays  says
Teva is primed for a big bounce after years of underperformance, Barclays says

Teva ponies up $420M to settle with investors who said company hid  price-fixing scheme | Fierce Pharma
Teva ponies up $420M to settle with investors who said company hid price-fixing scheme | Fierce Pharma

Teva Settles Price-Fixing-Related Securities Class Action Litigation for  $420 Million | The D&O Diary
Teva Settles Price-Fixing-Related Securities Class Action Litigation for $420 Million | The D&O Diary

Trouble at Teva: US price-fixing lawsuit adds to generic giant's woes -  Pharma Technology Focus | Issue 85 | August 2019
Trouble at Teva: US price-fixing lawsuit adds to generic giant's woes - Pharma Technology Focus | Issue 85 | August 2019

Teva Class Action Claims Company Suppressed Competition For Generic Version  Of MS Drug Copaxone - Top Class Actions
Teva Class Action Claims Company Suppressed Competition For Generic Version Of MS Drug Copaxone - Top Class Actions

Teva faces class-action lawsuit over US antitrust probe into price-fixing |  The Times of Israel
Teva faces class-action lawsuit over US antitrust probe into price-fixing | The Times of Israel

Teva Pays $420 Million to End Generic-Drug Securities Suit (1)
Teva Pays $420 Million to End Generic-Drug Securities Suit (1)

Endo, Teva join $270M deal to wrap up Lidoderm pay-for-delay lawsuit |  Fierce Pharma
Endo, Teva join $270M deal to wrap up Lidoderm pay-for-delay lawsuit | Fierce Pharma

UNITED STATES DISTRICT COURT DISTRICT OF CONNECTICUT ONTARIO TEACHERS'  PENSION PLAN BOARD, Individually and as Lead Plaintiff
UNITED STATES DISTRICT COURT DISTRICT OF CONNECTICUT ONTARIO TEACHERS' PENSION PLAN BOARD, Individually and as Lead Plaintiff

Suffering from missteps, drugmaker Teva struggles to heal own ills | The  Times of Israel
Suffering from missteps, drugmaker Teva struggles to heal own ills | The Times of Israel

UNITED STATES DISTRICT COURT DISTRICT OF CONNECTICUT ONTARIO TEACHERS'  PENSION PLAN BOARD, Individually and as Lead Plaintiff
UNITED STATES DISTRICT COURT DISTRICT OF CONNECTICUT ONTARIO TEACHERS' PENSION PLAN BOARD, Individually and as Lead Plaintiff

Barrett's Class Action Opinions Under the Microscope, Plus: Two Possible  MDLs Target Teva | Law.com
Barrett's Class Action Opinions Under the Microscope, Plus: Two Possible MDLs Target Teva | Law.com

Rosen Law Firm Files Securities Class Action Lawsuit Against Teva  Pharmaceutical Industries Limited - TEVA
Rosen Law Firm Files Securities Class Action Lawsuit Against Teva Pharmaceutical Industries Limited - TEVA

Teva settles investor lawsuit for $420m - Globes
Teva settles investor lawsuit for $420m - Globes

Tentative $161.5 million settlement reached in opioid trial
Tentative $161.5 million settlement reached in opioid trial

Teva enters opioid settlement agreement with US state Rhode Island
Teva enters opioid settlement agreement with US state Rhode Island

$135 Million Settlement in Illinois AWP Litigation Against Teva  Pharmaceuticals USA, Inc. | Miner, Barnhill & Galland, P.C.
$135 Million Settlement in Illinois AWP Litigation Against Teva Pharmaceuticals USA, Inc. | Miner, Barnhill & Galland, P.C.

Teva to pay $54M to settle whistleblower lawsuit - Philadelphia Business  Journal
Teva to pay $54M to settle whistleblower lawsuit - Philadelphia Business Journal

Teva Shareholder Notice
Teva Shareholder Notice

Teva Pharmaceuticals Retirement Savings Plan $2.55M Class Action Settlement  - Top Class Actions
Teva Pharmaceuticals Retirement Savings Plan $2.55M Class Action Settlement - Top Class Actions